Marrone Bio Innovations

Marrone Bio Innovations Capital Expenditures

Delisted

The Capital Expenditures (CapEx) of Marrone Bio Innovations (MBII) as of Nov 4, 2026 is -1.09 M USD. In the previous year, Capital Expenditures (CapEx) was -559,000.00 USD — a change of 95.53% (lower).

Capital Expenditures

-1.09 MUSD

YoY

95.53%

Last updated:

Capital Expenditures (CapEx) of Marrone Bio Innovations is 2021 -1.09 M USD. Capital Expenditures (CapEx) of Marrone Bio Innovations was 2020 -559,000.00 USD. It decreases by 95.53% lower compared to the previous year.

The Marrone Bio Innovations Capital Expenditures history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Capital Expenditures
Date
Capital Expenditures
Jan 1, 2014
-13.00 M USD
Jan 1, 2015
-13.00 M USD
Jan 1, 2016
-209,000.00 USD
Jan 1, 2017
-849,000.00 USD
Jan 1, 2018
-580,000.00 USD
Jan 1, 2019
-296,000.00 USD
Jan 1, 2020
-559,000.00 USD
Jan 1, 2021
-1.09 M USD
The Marrone Bio Innovations Capital Expenditures history
YEARCapital ExpendituresYoY
-1.09 MUSD+95.53%
-559,000.00USD+88.85%
-296,000.00USD-48.97%
-580,000.00USD-31.68%
-849,000.00USD+306.22%
-209,000.00USD-98.39%
-13.00 MUSD0.00%
-13.00 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Marrone Bio Innovations Stock analysis

What does Marrone Bio Innovations do? Marrone Bio Innovations Inc is an American company that has been operating in the field of biological pest control since 2006. It was founded by chemist Dr. Pamela Marrone and is headquartered in Davis, California. The company's business model is based on developing safe and effective biological pest control products made from natural ingredients. The aim is to minimize the environmental impact of agriculture. The company is divided into different divisions, including biological plant protection, biological nitrogen fixation, biological weed control, and other products. Some of the well-known products include Regalia®, Venerate®, and Majestene®. Marrone Bio Innovations has gained significance in recent years and is now one of the leading companies in the field of biological pest control. The company works closely with farmers, research institutions, and regulatory authorities to develop and introduce new products, always prioritizing safety and environmental compatibility. Marrone Bio Innovations is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Marrone Bio Innovations stock

Capital Expenditures (CapEx) of Marrone Bio Innovations is -1.09 M USD in 2021.

Capital Expenditures (CapEx) of Marrone Bio Innovations changed from -559,000.00 USD to -1.09 M USD, representing a 95.53% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Capital Expenditures (CapEx) Marrone Bio Innovations since 2006 – with annual values, charts, and detailed analysis.

Capital expenditures represent investments in long-term assets such as property, equipment, and technology. CapEx is essential for maintaining and growing the business.

Capital Expenditures (CapEx)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Capital Expenditures (CapEx)'s Marrone Bio Innovations historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Marrone Bio Innovations

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Marrone Bio Innovations